Ardeparin Subcutaneous and Moxetumomab Pasudotox-tdfk
Determining the interaction of Ardeparin Subcutaneous and Moxetumomab Pasudotox-tdfk and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ardeparin
Brand name: Baciguent, Probiotic Formula, Proferrin-ES
Synonyms: Ardeparin (Subcutaneous)
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ardeparin Subcutaneous-Moxetumomab pasudotox-tdfk Intravenous
- Ardeparin Subcutaneous-Moxifloxacin
- Ardeparin Subcutaneous-Moxifloxacin (Systemic)
- Ardeparin Subcutaneous-Moxifloxacin Hydrochloride
- Ardeparin Subcutaneous-Moxifloxacin Injection
- Ardeparin Subcutaneous-Moxifloxacin Intravenous
- Moxetumomab Pasudotox-tdfk-Aredia
- Moxetumomab Pasudotox-tdfk-Arestin
- Moxetumomab Pasudotox-tdfk-Arestin eent
- Moxetumomab Pasudotox-tdfk-Arestin mucous membrane powder
- Moxetumomab Pasudotox-tdfk-Arformoterol
- Moxetumomab Pasudotox-tdfk-Arformoterol inhalation